EDG4 Antikörper (AA 8-27)
Kurzübersicht für EDG4 Antikörper (AA 8-27) (ABIN7139908)
Target
Alle EDG4 (LPAR2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 8-27
- 
                                            Kreuzreaktivität
- Human
- 
                                            Aufreinigung
- >95%, Protein G purified
- 
                                            Immunogen
- Peptide sequence from Human Lysophosphatidic acid receptor 2 protein (8-27AA)
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:500-1:1000,
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C,-80 °C
- 
                                            Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - EDG4 (LPAR2) (Lysophosphatidic Acid Receptor 2 (LPAR2))
- 
                                            Andere Bezeichnung
- LPAR2
- 
                                            Hintergrund
- 
                        Background: Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. Seems to be coupled to the G(i)/G(o), G(12)/G(13), and G(q) families of heteromeric G proteins. Plays a key role in phospholipase C-beta (PLC-beta) signaling pathway. Stimulates phospholipase C (PLC) activity in a manner that is independent of RALA activation. Aliases: EDG 4 antibody, EDG-4 antibody, EDG4 antibody, Endothelial Cell Differentiation Gene 4 antibody, Endothelial differentiation lysophosphatidic acid G protein coupled receptor 4 antibody, FLJ93869 antibody, G protein coupled receptor antibody, IPA2 antibody, LPA 2 antibody, LPA receptor 2 antibody, LPA receptor EDG4 antibody, LPA-2 antibody, LPA2 antibody, LPAR2 antibody, LPAR2_HUMAN antibody, Lysophosphatidic acid receptor 2 antibody, Lysophosphatidic acid receptor Edg 4 antibody, Lysophosphatidic acid receptor Edg-4 antibody, Lysophosphatidic acid receptor EDG4 antibody 
- 
                                            UniProt
- Q9HBW0
 Target
- 
                    
 
                                     
                                     
                                    